class=”sc-29f61514-0 icZBHN”>
The man has big plans! In his first interview since taking office, Roche’s new CEO Thomas Schinecker (48) lays out the rules that Roche’s pharmaceutical industry must accelerate. In an interview with “NZZ am Sonntag” he emphasized that the group has grown stronger than is generally perceived. And he gives concrete numbers: “If you subtract the extraordinary sales that resulted from the Covid pandemic last year and are no longer there, our current sales growth is 8 percent.”
However, the German-Austrian dual citizen is not happy about this. To further fill out its new product portfolio, it is clearly incorporating acquisitions into its strategy. And he says: “We could also dream of a larger acquisition. “If it makes scientific and financial sense.” This is not surprising as there is financial scope for such acquisitions.
“There is room for improvement here”
Schinecker also attaches importance to research. As “NZZ am Sonntag” says, it wants to optimize and speed up research processes. The annual budget for the three research locations in Basel, California and Japan is 14 billion francs. That’s a lot of money, even for a giant like Roche. It is not surprising that there is also criticism. Schinecker is primarily blamed for lack of productivity. He responds: “We are definitely stronger than others in terms of the number of projects, but quantity alone is not a criterion for me. There is room for improvement here.”
Rarely does a senior executive speak so openly. “We have a number of projects where we are just in the middle of the field,” he admits. Then he wants to pull the rope. And increasingly the focus is only on “highly innovative projects.” He also denies that Roche is one of the drivers of ever-rising health insurance premiums. And he confidently claims: “Drug prices in Switzerland have hardly increased in recent years.” The benefits brought by innovative treatments are not always taken into account in discussions about drug prices. (pbe)
Source :Blick
I’m Tim David and I work as an author for 24 Instant News, covering the Market section. With a Bachelor’s Degree in Journalism, my mission is to provide accurate, timely and insightful news coverage that helps our readers stay informed about the latest trends in the market. My writing style is focused on making complex economic topics easy to understand for everyone.
